Price (delayed)
$0.8619
Market cap
$14.47M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.54
Enterprise value
$16.73M
Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company's proprietary MicroPulse® ...
Highlights
The net income is up by 19% QoQ and by 7% YoY
The EPS has increased by 19% QoQ and by 8% YoY
Iridex's debt has soared by 69% YoY but it has decreased by 5% from the previous quarter
IRIX's gross profit is down by 11% year-on-year but it is up by 3.7% since the previous quarter
IRIX's equity has dropped by 78% year-on-year and by 20% since the previous quarter
The quick ratio has declined by 50% year-on-year and by 11% since the previous quarter
Key stats
What are the main financial stats of IRIX
MarketValuationsEarnings
Shares outstanding
16.79M
Market cap
$14.47M
Enterprise value
$16.73M
Price to earnings (P/E)
N/A
Price to book (P/B)
6.84
Price to sales (P/S)
0.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.34
Revenue
$48.67M
Gross profit
$19.5M
Operating income
-$8.3M
Net income
-$8.91M
EBIT
-$8.84M
EBITDA
-$7.42M
Free cash flow
-$7.3M
Per shareBalance sheetLiquidity
EPS
-$0.54
EPS diluted
-$0.54
Free cash flow per share
-$0.44
Book value per share
$0.13
Revenue per share
$2.96
TBVPS
$1.63
Total assets
$29.14M
Total liabilities
$27.04M
Debt
$4.64M
Equity
$2.1M
Working capital
$7M
Debt to equity
2.21
Current ratio
1.42
Quick ratio
0.65
Net debt/EBITDA
-0.3
MarginsEfficiencyDividend
EBITDA margin
-15.2%
Gross margin
40.1%
Net margin
-18.3%
Operating margin
-17.1%
Return on assets
-28.6%
Return on equity
-230.6%
Return on invested capital
-72.2%
Return on capital employed
-70.3%
Return on sales
-18.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IRIX stock price
How has the Iridex stock price performed over time
Intraday
-9.27%
1 week
-13.73%
1 month
-30.49%
1 year
-70.58%
YTD
-48.7%
QTD
-12.94%
Financial performance
How have Iridex's revenue and profit performed over time
Revenue
$48.67M
Gross profit
$19.5M
Operating income
-$8.3M
Net income
-$8.91M
Gross margin
40.1%
Net margin
-18.3%
IRIX financials
The operating margin rose by 24% since the previous quarter and by 11% year-on-year
IRIX's operating income is up by 24% since the previous quarter and by 17% year-on-year
Iridex's net margin has increased by 20% from the previous quarter
The net income is up by 19% QoQ and by 7% YoY
Growth
What is Iridex's growth rate over time
IRIX growth chart
Valuation
What is Iridex stock price valuation
P/E
N/A
P/B
6.84
P/S
0.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.34
Price to earnings (P/E)
The EPS has increased by 19% QoQ and by 8% YoY
Price to book (P/B)
IRIX's equity has dropped by 78% year-on-year and by 20% since the previous quarter
The price to book (P/B) is 68% higher than the 5-year quarterly average of 4.5 but 25% lower than the last 4 quarters average of 10.1
Price to sales (P/S)
The stock's price to sales (P/S) is 71% less than its 5-year quarterly average of 1.1 and 54% less than its last 4 quarters average of 0.7
The revenue has declined by 6% year-on-year
Efficiency
How efficient is Iridex business performance
Iridex's ROE has decreased by 20% from the previous quarter
The ROS has increased by 19% QoQ
IRIX's return on invested capital is up by 16% since the previous quarter but it is down by 15% year-on-year
The company's return on assets rose by 16% QoQ but it fell by 10% YoY
Dividends
What is IRIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IRIX.
Financial health
How did Iridex financials performed over time
Assets vs liabilities
Iridex's total assets is 8% higher than its total liabilities
The quick ratio has declined by 50% year-on-year and by 11% since the previous quarter
The company's current ratio fell by 33% YoY and by 8% QoQ
Debt vs equity
Iridex's debt is 121% more than its equity
IRIX's equity has dropped by 78% year-on-year and by 20% since the previous quarter
Iridex's debt has soared by 69% YoY but it has decreased by 5% from the previous quarter
Balance sheet
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from 
and Sharadar.